Menu
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.95

€0.95

-2.160%
-0.021
-2.160%
-
 
10.04.26 / Frankfurt WKN: A2DS5F / Name: Valbiotis / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Valbiotis Stock

We can see a decrease in the price for Valbiotis. Compared to yesterday it has lost -€0.021 (-2.160%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Valbiotis stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Valbiotis in the next few years

Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Valbiotis vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Valbiotis -2.160% - - - - - -
Cerenis Therapeutics Holding S.A. 0.570% -2.743% 7.587% 209.878% 3.353% 82.169% 249.606%
Sensorion SA 0.130% -8.234% -31.093% - - - -
Genoway S.A. Inh. 0.000% -3.361% 5.505% -19.298% -7.258% -35.574% -38.992%

News

VALBIOTIS SA: Valbiotis announces launch of operations in Asia
VALBIOTIS SA: Valbiotis announces launch of operations in Asia
VALBIOTIS SA: Valbiotis announces launch of operations in Asia
VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
VALBIOTIS SA: 2025 Financial Results
VALBIOTIS SA: 2025 Financial Results
VALBIOTIS SA: 2025 Financial Results